Fecal immunochemical testing increases CRC screening, diagnoses

Fecal immunochemical testing increases CRC screening, diagnoses

Increased use of fecal immunochemical testing correlated with more colorectal cancer screenings and early-stage diagnoses amid the COVID-19 pandemic, according to research in JAMA Network Open.“When CMS recommended delaying all non-urgent procedures, including screening colonoscopies, CRC screening declined by 90%,”,” Rachel B. Issaka, MD, MAS, Hutchinson Cancer Research Center in Seattle, Wash., told Healio. “We described how stool-based tests, including the fecal immunochemical test (FIT), had the potential to improve CRC screening and detection during the pandemic,Read More

Share on facebook
Share on twitter
Share on linkedin